What are the prospects for controlling hepatitis C?
- PMID: 19529757
- PMCID: PMC2688087
- DOI: 10.1371/journal.pmed.1000096
What are the prospects for controlling hepatitis C?
Conflict of interest statement
PK and EB currently work on an EU-funded vaccine program (HEPACIVAC) that includes Okairos as a collaborator. PK also reports acting as a consultant on the immunology of HCV for Pfizer, Intercell, and Tibotec.
Figures
Comment on
-
A novel diagnostic target in the hepatitis C virus genome.PLoS Med. 2009 Feb 10;6(2):e31. doi: 10.1371/journal.pmed.1000031. PLoS Med. 2009. PMID: 19209955 Free PMC article.
References
-
- World Hepatitis Alliance. World Hepatitis Day. 2009 Available: http://www.worldhepatitisday.org/. Accessed 11 May 2009.
-
- Klenerman P, Kim A. HCV–HIV coinfection: Simple messages from a complex disease. PLoS Med. 2007;4:e240. doi: 10.1371/journal.pmed.0040240. - DOI - PMC - PubMed
-
- Houghton M. Discovery of the hepatitis C virus. Liver Int. 2009;29(Suppl 1):82–88. - PubMed
-
- Simmonds P. Genetic diversity and evolution of hepatitis C virus—15 years on. J Gen Virol. 2004;85:3173–3188. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
